Investigación / Grupos de investigación

Grupo  3

Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Publicaciones (557)

  • GIL, S.; CARBONELL, D.; LOPEZ, L.; MIGUENS, I.; ALONSO, R.; BUÑO, I.; Muñoz, P.; Ochando Cano, Jordi; PION, M.; CORREA, R..

    Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days

    Frontiers in Immunology. 2021; 12: 726960-726960 Nº de citas: 18 [doi:10.3389/fimmu.2021.726960]

  • Martin-Rojas, RM; Chasco-Ganuza, M; Casanova-Prieto, S; Delgado-Pinos, VE; Perez-Rus, G; Duque-Gonzalez, P; Sancho, M; Diez-Martin, JL; Pascual-Izquierdo, C.

    A mild deficiency of ADAMTS13 is associated with severity in COVID-19: comparison of the coagulation profile in critically and noncritically ill patients

    BLOOD COAGULATION & FIBRINOLYSIS. 2021; 32(7): 458-467 Nº de citas: 10 [doi:10.1097/MBC.0000000000001068]

  • Martinez-Solano, J; Ortiz-Bautista, C; Zatarain-Nicolas, E; Sousa-Casasnovas, I; Pedraz-Prieto, A; Barrio-Gutierrez, JM; Pascual-Izquierdo, C; Fernandez-Aviles, F.

    Management of Intracranial Hemorrhage During Pulsatile Long-Term Biventricular Support: When Necessity Is the Mother of Invention

    ASAIO JOURNAL. 2021; 67(10): 172-175 [doi:10.1097/MAT.0000000000001353]

  • Ribera, JM; Morgades, M; Coll, R; Barba, P; Lopez-Lorenzo, JL; Montesinos, P; Foncillas, MA; Cabrero, M; Gomez-Centurion, I; Morales, MD; Varela, MR; Herrera, P; Garcia-Cadenas, I; Calbacho, M; Torrent, A; Maluquer, C; Calabuig, M; Garcia-Guinon, A; Bautista, G; Llorente, L; Gil, C; Artola, MT; Gonzalez-Campos, J; Fernandez-Moreno, A; Barez, A; Gimenez-Perez, T; Bergua, J; Sanchez-Sanchez, MJ; Mateos, MC; Pinana, JL.

    Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain

    Clinical Lymphoma Myeloma & Leukemia. 2021; 21(10): 801-809 Nº de citas: 16 [doi:10.1016/j.clml.2021.06.024]

  • Genesca, E; Morgades, M; Gonzalez-Gil, C; Fuster-Tormo, F; Haferlach, C; Meggendorfer, M; Montesinos, P; Barba, P; Gil, C; Coll, R; Moreno, MJ; Martinez-Carballeira, D; Garcia-Cadenas, I; Vives, S; Ribera, J; Gonzalez-Campos, J; Diaz-Beya, M; Mercadal, S; Artola, MT; Cladera, A; Tormo, M; Bermudez, A; Vall-llovera, F; Martinez-Sanchez, P; Amigo, ML; Monsalvo, S; Novo, A; Cervera, M; Garcia-Guinon, A; Ciudad, J; Cervera, J; Hernandez-Rivas, JM; Granada, I; Haferlach, T; Orfao, A; Sole, F; Ribera, JM.

    Adverse prognostic impact of complex karyotype (>= 3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)

    LEUKEMIA RESEARCH. 2021; 109: 106612-106612 Nº de citas: 12 [doi:10.1016/j.leukres.2021.106612]

  • Ribera, JM; Morgades, M; Genesca, E; Chapchap, EC; Montesinos, P; Acuna-Cruz, E; Gil, C; Garcia-Cadenas, I; Barba, P; Gonzalez-Campos, J; de Llano, MPQ; Torrent, A; Ribera, J; Granada, I; Bernal, T; Diaz-Beya, M; Amigo, ML; Coll, R; Tormo, M; Vall-llovera, F; Gomez-Centurion, I; Sanchez-Sanchez, MJ; Soria, B; Cladera, A; Artola, MT; Garcia-Guinon, A; Gimenez-Conca, A; Amador, ML; Martinez-Sanchez, P; Algarra, JL; Vidal, MJ; Alonso, N; Maluquer, C; Llorente, L; Garcia-Boyero, R; Ciudad, J; Feliu, E; Orfao, A; PETHEMA Grp.

    Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials

    HEMATOLOGICAL ONCOLOGY. 2021; 39(4): 529-538 Nº de citas: 8 [doi:10.1002/hon.2910]

  • Ljungman, P; de la Camara, R; Mikulska, M; Tridello, G; Aguado, B; Al Zahrani, M; Apperley, J; Berceanu, A; Bofarull, RM; Calbacho, M; Ciceri, F; Lopez-Corral, L; Crippa, C; Fox, ML; Grassi, A; Jimenez, MJ; Demir, SK; Kwon, M; Llamas, CV; Lorenzo, JLL; Mielke, S; Orchard, K; Porras, RP; Vallisa, D; Xhaard, A; Knelange, NS; Cedillo, A; Kroger, N; Pinana, JL; Styczynski, J.

    COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey

    LEUKEMIA. 2021; 35(10): 2885-2894 Nº de citas: 191 [doi:10.1038/s41375-021-01302-5]

  • Esquirol, A; Pascual, MJ; Kwon, M; Perez, A; Parody, R; Ferra, C; Cadenas, IG; Herruzo, B; Dorado, N; Hernani, R; Sanchez-Ortega, I; Torrent, A; Sierra, J; Martino, R.

    Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

    BONE MARROW TRANSPLANTATION. 2021; 56(10): 2432-2444 Nº de citas: 55 [doi:10.1038/s41409-021-01328-4]

  • Amor-Garcia, MA; Fernandez-Llamazares, CM; Manrique-Rodriguez, S; Narrillos-Moraza, A; Garcia-Morin, M; Huerta-Aragones, J; Sanjurjo-Saez, M.

    Bromocriptine for the treatment of postoperative cerebellar mutism syndrome in pediatric patients: Three case reports

    JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2021; 27(7): 1753-1757 Nº de citas: 10 [doi:10.1177/1078155220982046]

  • Perez-Garcia, F; Bailen, R; Torres-Macho, J; Fernandez-Rodriguez, A; Jimenez-Sousa, MA; Jimenez, E; Perez-Butragueno, M; Cuadros-Gonzalez, J; Cadinanos, J; Garcia-Garcia, I; Jimenez-Gonzalez, M; Ryan, P; Resino, S.

    Age-Adjusted Endothelial Activation and Stress Index for Coronavirus Disease 2019 at Admission Is a Reliable Predictor for 28-Day Mortality in Hospitalized Patients With Coronavirus Disease 2019

    Frontiers In Medicine. 2021; 8: 736028-736028 Nº de citas: 7 [doi:10.3389/fmed.2021.736028]

  • Sharda E; Patel RS; Juárez-Salcedo LM; Dalia S; Hanna CH; Gruhonjic H; Ponnaganti BS; Mhaskar R.

    Adverse events of radioimmunotherapy for non-Hodgkin lymphoma: A systematic review and meta-analysis

    LEUKEMIA RESEARCH. 2021; 108: 106615-106615 [doi:10.1016/j.leukres.2021.106615]

  • Pérez-Lago L; Martínez-Lozano H; Pajares Díaz JA; Díaz Gómez A; Machado M; Sola-Campoy PJ; Herranz M; Buenestado-Serrano S; Valerio M; Olmedo M; Andrés Zayas C; Comas I; González Candelas F; Bañares R; Catalán P; Muñoz P; García de Viedma D.

    Proper Assignation of Reactivation in a COVID-19 Recurrence Initially Interpreted as a Reinfection.

    JOURNAL OF INFECTIOUS DISEASES. 2021; 224(5): 788-792 Nº de citas: 4 [doi:10.1093/infdis/jiab302]

  • Pérez Lago L; Pérez Latorre L; Herranz M; Tejerina F; Sola-Campoy PJ; Sicilia J; Suárez-González J; Andrés-Zayas C; Chiner-Oms A; Jiménez-Serrano S; García-González N; Comas I; González-Candelas F; Martínez-Laperche C; Catalán P; Muñoz P; García de Viedma D.

    Complete Analysis of the Epidemiological Scenario around a SARS-CoV-2 Reinfection: Previous Infection Events and Subsequent Transmission

    mSphere. 2021; 6(5): Nº de citas: 2 [doi:10.1128/mSphere.00596-21]

  • Martinez-Trufero, J; Jurado, JC; Gomez-Mateo, MC; Bernabeu, D; Floria, LJ; Lavernia, J; Sebio, A; del Muro, XG; Alvarez, R; Correa, R; Hernandez-Leon, CN; Marquina, G; Hindi, N; Redondo, A; Martinez, V; Asencio, JM; Mata, C; Morales, CMV; Martin-Broto, J.

    Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations for diagnosis and treatment. Spanish group for Sarcoma research (GEIS - GROUP). Part I

    CANCER TREATMENT REVIEWS. 2021; 99: 102259-102259 Nº de citas: 6 [doi:10.1016/j.ctrv.2021.102259]

  • Martinez-Trufero, J; Jurado, JC; Hernandez-Leon, CN; Correa, R; Asencio, JM; Bernabeu, D; Alvarez, R; Hindi, N; Mata, C; Marquina, G; Martinez, V; Redondo, A; Floria, LJ; Gomez-Mateo, MC; Lavernia, J; Sebio, A; del Muro, XG; Martin-Broto, J; Valverde-Morales, C.

    Uncommon and peculiar soft tissue sarcomas: Multidisciplinary review and practical recommendations. Spanish Group for Sarcoma research (GEIS -GROUP). Part II

    CANCER TREATMENT REVIEWS. 2021; 99: 102260-102260 Nº de citas: 9 [doi:10.1016/j.ctrv.2021.102260]

  • Andres-Zayas, C; Suarez-Gonzalez, J; Rodriguez-Macias, G; Dorado, N; Osorio, S; Font, P; Carbonell, D; Chicano, M; Muniz, P; Bastos, M; Kwon, M; Diez-Martin, JL; Buno, I; Martinez-Laperche, C.

    Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition

    MOLECULAR ONCOLOGY. 2021; 15(9): 2273-2284 Nº de citas: 7 [doi:10.1002/1878-0261.12921]

  • Kharfan-Dabaja, MA; Labopin, M; Bazarbachi, A; Ciceri, F; Finke, J; Bruno, B; Bornhauser, M; Gedde-Dahl, T; Labussiere-Wallet, H; Niittyvuopio, R; Valerius, T; Angelucci, E; Brecht, A; Caballero, D; Kuball, J; Potter, V; Schmid, C; Tischer, J; Zuckerman, T; Benedetti, F; Blaise, D; Diez-Martin, JL; Sanz, J; Ruggeri, A; Brissot, E; Savani, BN; Giebel, S; Nagler, A; Mohty, M.

    Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT

    BONE MARROW TRANSPLANTATION. 2021; 56(9): 2194-2202 Nº de citas: 13 [doi:10.1038/s41409-021-01317-7]

  • Pérez-Lago L; Martínez-Lozano H; Pajares-Díaz JA; Díaz-Gómez A; Machado M; Sola-Campoy PJ; Herranz M; Valerio M; Olmedo M; Suárez-González J; Quesada-Cubo V; Gómez-Ruiz MDM; López-Fresneña N; Sánchez-Arcilla I; Comas I; González-Candelas F; García de San José S; Bañares R; Catalán P; Muñoz P; García de Viedma D.

    Overlapping of Independent SARS-CoV-2 Nosocomial Transmissions in a Complex Outbreak.

    mSphere. 2021; 6(4): Nº de citas: 9 [doi:10.1128/mSphere.00389-21]